Uzbekistan Brings Together the International Community at the UN to Strengthen the Fight Against Childhood Cancer
29.9.2025 10:59:00 CEST | Business Wire | Press Release
For the first time in the history of the United Nations General Assembly, Uzbekistan held a special event dedicated to “A global movement to improve survival and reduce suffering for children with cancer and other catastrophic diseases”.
The event was hosted by the Government of Uzbekistan, WHO, St. Jude Children’s Research Hospital and Zamin Foundation.
The event was attended by the First Ladies of Azerbaijan, Angola, Vietnam, Guatemala, Serbia, and Türkiye, the spouse of the Prime Minister of Lebanon, the Director-General of WHO, the President of ECOSOC, the President and leadership of St. Jude Children’s Research Hospital, as well as the Ministers of Health of Angola, Armenia, Bangladesh, Mozambique, the Dominican Republic, Nigeria, Kazakhstan, Qatar, the Republic of the Congo, Kyrgyzstan, Malta, Mongolia, the UAE, Peru, Tajikistan, Timor-Leste, Tuvalu, Türkiye, Chad, and Jamaica, along with representatives of healthcare authorities of Hungary, Indonesia, Russia and Tanzania, international organizations, experts and civil society representatives.
The event showcased the results of the Global Initiative for Childhood Cancer and the Global Platform for Access to Childhood Cancer Medicines. Participants reaffirmed their commitment to achieving a 60% survival rate for children with cancer by 2030 through the development of equitable, integrated and locally resourced health systems.
In her address to the participants of the event, chair of the Board of Trustees of the Zamin Foundation Ziroat Mirziyoyeva mentioned:
"Currently, more than 2 billion children worldwide are at risk or suffer from non-communicable diseases. That is almost a third of the world's population. Millions of them are fighting cancer. Despite the achievements of modern medicine, survival rates remain uneven: in developed countries, they are above 80%, while in developing countries, they are below 30%. This is an unacceptable gap. We are obliged to take steps in order to prevent this tragedy!"
In his address, Director-General of the World Health Organization Dr. Tedros Adhanom Ghebreyesus underlined emphasized: “Every child suffering from cancer deserves an equal right to fight for their life, regardless of the country or community they come from. That is why we launched the WHO Global Initiative for Childhood Cancer. The results speak for themselves: the program has helped more than 400 thousand children in 80 low- and middle-income countries”.
Speaking at the event, St. Jude Children’s Research Hospital President James R. Downing stated: “To fulfill our promise that no child should die at the dawn of life, we are laying the foundations of the Global Sickle Cell Disease Initiative, aimed at improving survival rates among children with this condition. I call on every United Nations member state to join both global initiatives. This must become a priority for all countries”.
Children affected by these diseases became special guests of the event. Their touching stories deeply resonated with the participants. From Uzbekistan, young graduate and volunteer of Mehrli maktab, Samira Idrisova, shared her journey.
Uzbekistan is actively contributing to the global movement for children’s health. In recent years, the country has implemented large-scale programs to reduce child cancer mortality, mobilized additional resources, introduced new standards for diagnosis and treatment, and expanded access to medicines.
The country has adopted the National Strategy to Combat Childhood Cancer for 2025–2030, aligned with the WHO’s CureAll framework. The strategy envisions raising the early detection rate to 65%, increasing one-year survival from 34% to 90%, five-year survival to 60%, and ensuring 100% access to specialized multidisciplinary care.
Moreover, an International Academic Hub for Childhood Cancer has been established in Tashkent aimed at facilitating the integration of international standards in diagnostics, specialist training, and innovation, as well as the exchange of best practices and the development of modern clinical research.
The event became an important international platform for the exchange of expertise, demonstration of solidarity and promotion of innovative solutions in addressing one of the most pressing and often underestimated challenges in global healthcare.
The discussion continued with panel sessions focused on sustaining progress in childhood cancer treatment and implementing the global initiative to combat sickle cell anemia.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250926977972/en/
Contacts
For more information, please contact:
Elena Ikaeva
Director of the Department on media and public relations, IPF Zamin
Phone: +998 712052525
+998 935645050
E-mail: e.ikaeva@zaminfoundation.ngo
https://zaminfoundation.ngo/en/about -
https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fzaminfoundatio
n.ngo%2Fen%2Fabout&esheet=54330372&newsitemid=20250926977972&lan=en-US&anchor=ht
tps%3A%2F%2Fzaminfoundation.ngo%2Fen%2Fabout&index=1&md5=3977c661221018741b0cade
6f464b7f3
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma’s Relfydess™ (relabotulinumtoxinA) Receives Approval in China for Frown Lines23.10.2026 07:00:00 CEST | Press Release
Galderma (SIX: GALD) today announced that the Chinese NMPA has approved Relfydess for the temporary improvement of moderate-to-severe frown lines in adults, marking a significant expansion of the company’s Injectable Aesthetics portfolio in China – one of the world's largest and fastest-growing aesthetics markets.8,9 This approval follows successful authorizations and launches of Relfydess in more than 35 markets worldwide. Relfydess is the first and only ready-to-use liquid neuromodulator developed with PEARL Technology, designed to deliver a highly active, innovative, complex-free molecule that addresses the real needs of patients and healthcare professionals.1,2,4,5 It is optimized for simple volumetric dosing, without reconstitution, to increase ease-of-use and help ensure consistent dose/volume every time.1,10 At a time whenpatients and healthcare professionals are increasingly seeking high-performance neuromodulators that rapidly deliver long-lasting, natural-looking outcomes, Re
Mundipharma Announces Further Phase III ReSPECT Results Presented as a Late-Breaking Oral Presentation at IDWeek 202622.10.2026 19:03:00 CEST | Press Release
Today Mundipharma announced additional results from the global Phase III ReSPECT clinical trial evaluating REZZAYO®(rezafungin acetate) for prophylaxis of invasive fungal diseases (IFDs) in adult patients undergoing allogeneic haematopoietic stem cell transplantation (allo-HSCT). The Phase III findings were presented today as a late-breaking oral presentation at IDWeek 2026. The presentation provides additional detail following the top line ReSPECT results announced in April 2026, including further endpoint analyses, the components contributing to fungal-free survival (FFS), pre-specified sensitivity analyses and detailed safety outcomes. The additional analyses were consistent with the previously announced topline findings. ReSPECT was a global, multicentre, randomised, double-blind Phase III study in which 402 patients were randomised to rezafungin and 200 to the standard antimicrobial regimen. As previously announced, the study met its primary endpoint, demonstrating non-inferiority
Tigo Energy Improves Installer Choice via Fronius Compatibility with TS4 Product Line22.10.2026 18:02:00 CEST | Press Release
Tigo Energy, Inc. (NASDAQ: TYGO) (“Tigo” or “Company”), a leading provider of intelligent solar and energy software solutions, today announced a manufacturer declaration of compatibility from Fronius International GmbH, documenting compatibility between Tigo Flex MLPE products and multiple Fronius inverter families. The letter covers Tigo TS4-A-F, TS4-A-2F, TS4-A-O, and TS4-X-O products and the Fronius Primo GEN24, Primo GEN24 208-240, Symo GEN24, Verto, Tauro, and Tauro ECO inverter families, when configured according to the requirements specified by Fronius and Tigo. Building on established compatibility in Europe, the declaration extends manufacturer-confirmed compatibility to markets worldwide, including the United States and Canada, giving solar professionals greater flexibility to design high-quality systems using manufacturer-confirmed technology combinations. Fronius develops solar technologies and solutions for residential, commercial, and large-scale applications, with a port
Saudi Maritime & Logistics Congress Highlights Maritime Sector Integration and Opportunities for Trade and Investment Growth in the Kingdom22.10.2026 16:52:00 CEST | Press Release
The Saudi Maritime & Logistics Congress highlighted Saudi Arabia’s role in supporting the continuity of trade flows and strengthening supply chain resilience as it opened at Jeddah Superdome, bringing together representatives of government entities, maritime transport and logistics leaders, and the business community. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261022362613/en/ The Congress takes place as rapid changes in trade and shipping prompt companies to reassess transport routes and operational and investment choices. It provides a platform for dialogue among stakeholders to explore opportunities for cooperation and strengthen integration between ports and maritime, land transport and logistics services, supporting operational efficiency and supply chain reliability. In his opening address, His Excellency Eng. Fawaz Alsahli, President of the Transport General Authority in Saudi Arabia, emphasised that the Kingdom’s
Ministerial Roundtable Discusses Mobilising Green Investments for a Resilient and Inclusive Global Economy22.10.2026 16:49:00 CEST | Press Release
HE Saeed Mohammed Al Tayer, Chairman of the World Green Economy Organization, opened the Ministerial Roundtable titled "From Ambition to Bankable Action-Mobilising Green Investments for a Resilient and Inclusive Global Economy," during the 12th World Green Economy Summit (WGES), held on 21-22 October 2026 at the Dubai World Trade Centre under the theme "From Success to Scale: Showcasing the Green Economy." This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261022803264/en/ Ministerial Roundtable Discusses Mobilising Green Investments for a Resilient and Inclusive Global Economy (Photo: AETOSWire) The session was attended by HE Dr. Amna bint Abdullah Al Dahak, Minister of Climate Change and Environment, the United Arab Emirates; HE Aliou Gori Diouf, Minister of Environment and Ecological Transition, Senegal; HE Balarabe Abbas Lawal, Minister of Environment, Nigeria; HE Steven Victor, Minister of Agriculture, Fisheries, and the En
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom